PRESS RELEASE published on 08/28/2023 at 13:30, 2 years 7 months ago NLS Pharmaceutics CEO Issues Letter to Shareholders
PRESS RELEASE published on 05/02/2023 at 14:45, 2 years 11 months ago NLS Pharmaceutics Receives Green Light from the U.S. FDA to Proceed with Phase 3 Clinical Program (AMAZE) for Quilience(R) (Mazindol ER) for the Treatment of Narcolepsy
PRESS RELEASE published on 03/27/2023 at 14:30, 3 years ago NLS Pharmaceutics Announces Open Label Extension Study Six-Month Data for Quilience(R) (Mazindol ER) in the Treatment of Narcolepsy Type 1 and Type 2
PRESS RELEASE published on 01/23/2023 at 14:30, 3 years 2 months ago NLS Pharmaceutics Announces New In-Vitro Data Reconfirming Quilience's(R) (Mazindol ER) Unique Dual Mechanism of Action Involving Significant Orexin-2 Receptor Activity
PRESS RELEASE published on 01/12/2023 at 14:30, 3 years 3 months ago NLS Pharmaceutics Announces an R&D Update Webcast to Review the Company's Growing Portfolio of Pre-Clinical Compounds
Published on 04/14/2026 at 10:55, 6 minutes ago Waton Financial Marks One Year as a Listed Company with MOTA: A New Chapter in Human-AI Investment Collaboration
Published on 04/14/2026 at 09:05, 1 hour 56 minutes ago BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
Published on 04/14/2026 at 09:01, 2 hours ago Star Copper Fully Funded 15,000 Metre Drill Program Targets Maiden Resource in 2026
Published on 04/13/2026 at 23:15, 11 hours 46 minutes ago Relevant Gold Completes Strategic Financing; Embarks on Largest Drilling Program in Company History
Published on 04/13/2026 at 23:00, 12 hours 1 minute ago Sterling Metals Announces Sale Of Sail Pond Project
Published on 04/14/2026 at 10:30, 31 minutes ago Baucor Boosts European Operations with Strategic Product Expansion
Published on 04/14/2026 at 10:00, 1 hour 1 minute ago ARTCLINE achieves milestone in septic shock: Patient recruitment for the ReActIF-ICE study successfully completed
Published on 04/14/2026 at 10:00, 1 hour 1 minute ago Waton Financial Marks One Year as a Listed Company with MOTA: A New Chapter in Human-AI Investment Collaboration
Published on 04/14/2026 at 09:57, 1 hour 4 minutes ago Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
Published on 04/14/2026 at 09:43, 1 hour 18 minutes ago GFT named Leader in QKS Spark Matrix™ 2026 for Insurance Digital Transformation Services, Driving Faster, Lower-Risk Transformation
Published on 04/14/2026 at 08:30, 2 hours 31 minutes ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 15 hours 47 minutes ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 16 hours 46 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
Published on 04/13/2026 at 18:15, 16 hours 46 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026
Published on 04/13/2026 at 18:09, 16 hours 52 minutes ago Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.
